Amrapali Biotech India Profile
Key Indicators
- Authorised Capital ₹ 12.50 Cr
as on 26-12-2024
- Paid Up Capital ₹ 12.00 Cr
as on 26-12-2024
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 47.33 Cr
as on 26-12-2024
- Satisfied Charges ₹ 0.95 M
as on 26-12-2024
- Revenue -76.74%
(FY 2017)
- Profit 65.22%
(FY 2017)
- Ebitda 84.31%
(FY 2017)
- Net Worth -110.70%
(FY 2017)
- Total Assets -14.81%
(FY 2017)
About Amrapali Biotech India
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 12.50 Cr and a paid-up capital of Rs 12.00 Cr.
The company currently has active open charges totaling ₹47.33 Cr. The company has closed loans amounting to ₹0.95 M, as per Ministry of Corporate Affairs (MCA) records.
Sunil Kumar, Sudhir Choudhary, and Ram Singh serve as directors at the Company.
- CIN/LLPIN
U24100DL2007PTC168163
- Company No.
168163
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2007
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Amrapali Biotech India Private Limited. offer?
Amrapali Biotech India Private Limited. offers a wide range of products and services, including Pickles, Jams & Ketchups, Jam, Vinegar, Fruit Vinegar, Sauces, Soya Sauce, Pickles, Corporate Finance & Leasing Advisors, Project Finance Consultants, Mixed Fruit Jam.
Who are the key members and board of directors at Amrapali Biotech India?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunil Kumar | Director | 15-Oct-2013 | Current |
Sudhir Choudhary | Director | 07-Mar-2018 | Current |
Ram Singh | Additional Director | 26-May-2019 | Current |
Financial Performance of Amrapali Biotech India.
Amrapali Biotech India Private Limited., for the financial year ended 2017, experienced significant reduction in revenue, with a 76.74% decrease. The company also saw a substantial improvement in profitability, with a 65.22% increase in profit. The company's net worth observed a substantial decline by a decrease of 110.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Amrapali Biotech India?
In 2017, Amrapali Biotech India had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Gaurisuta Buildhome Private LimitedActive 14 years 7 months
Sunil Kumar and Ram Singh are mutual person
- Gaurisuta Infrasolution Private LimitedActive 14 years 7 months
Sunil Kumar, Sudhir Choudhary and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Oriental Bank Of Commerce Creation Date: 20 Apr 2011 | ₹24.83 Cr | Open |
Oriental Bank Of Commerce Creation Date: 13 Oct 2008 | ₹22.50 Cr | Open |
Bank Of Maharashtra Creation Date: 14 Nov 2007 | ₹0.95 M | Satisfied |
How Many Employees Work at Amrapali Biotech India?
Amrapali Biotech India has a workforce of 31 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amrapali Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amrapali Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.